Citation Impact
Citing Papers
Combined Functional Genomic Maps of the C. elegans DNA Damage Response
2002 Science
Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia
2002 Standout
Mutations in the NF-κB signaling pathway: implications for human disease
2006
Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death
1990 StandoutNature
Signal Transduction by the JNK Group of MAP Kinases
2000 Standout
Oncogenic kinase signalling
2001 StandoutNature
Shared Principles in NF-κB Signaling
2008 Standout
Transformation of hematopoietic cell lines to growth-factor independence and induction of a fatal myelo- and lymphoproliferative disease in mice by retrovirally transduced TEL/JAK2 fusion genes
1998
The Pathogenesis of Rheumatoid Arthritis
2011 Standout
Etiology and pathogenesis of preeclampsia: Current concepts
1998
Bcl-2 functions in an antioxidant pathway to prevent apoptosis
1993 Standout
Role of the retinoblastoma protein in the pathogenesis of human cancer.
1997 StandoutNobel
Nuclear factor-κB in cancer development and progression
2006 StandoutNature
Richter syndrome
2004
Pre-eclampsia
2005 Standout
Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair
1993 Standout
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
2005 Standout
Multiple small RNA pathways regulate the silencing of repeated and foreign genes in C. elegans
2013 StandoutNobel
A Cell Cycle Regulator Potentially Involved in Genesis of Many Tumor Types
1994 StandoutScience
Caenorhabditis elegans CED-9 protein is a bifunctional cell-death inhibitor
1997 StandoutNatureNobel
Sickle-cell disease
2010 Standout
Clinical Effect of Point Mutations in Myelodysplastic Syndromes
2011 Standout
Molecular themes in oncogenesis
1991 StandoutNobel
Chromosome aberrations in B-cell chronic lymphocytic leukemia: reassessment based on molecular cytogenetic analysis
1999
A novel gene, MDS2, is fused to ETV6/TEL in a t(1;12)(p36.1;p13) in a patient with myelodysplastic syndrome
2002
The Evi-1 oncoprotein inhibits c-Jun N-terminal kinase and prevents stress-induced cell death
2000
Atherosclerosis — An Inflammatory Disease
1999 Standout
Concomitant tetrasomy 3q and trisomy 18 in CD5−, CD13+ chronic lymphocytic leukemia
2002
Sarcoidosis
1997 Standout
Allogeneic Hematopoietic Stem-Cell Transplantation for Sickle Cell Disease
2009
Calcium and vitamin D metabolism in granulomatous diseases
1992
Genomic Aberrations and Survival in Chronic Lymphocytic Leukemia
2000 Standout
MicroRNA signatures in human cancers
2006 Standout
In B-cell chronic lymphocytic leukaemia chromosome 17 abnormalities and not trisomy 12 are the single most important cytogenetic abnormalities for the prognosis: A cytogenetic and immunophenotypic study of 480 unselected newly diagnosed patients
1997
Cytokine Signaling in 2002
2002 Standout
Homocysteinemia as a risk factor for atherosclerosis: a review
1997
Systematic analysis of genes required for synapse structure and function
2005 StandoutNatureNobel
Cancer-related inflammation
2008 StandoutNature
CARMA1, BCL-10 and MALT1 in lymphocyte development and activation
2004
Identification of Cyclobutane Pyrimidine Dimer-Responsive Genes Using UVB-Irradiated Human Keratinocytes Transfected with In Vitro-Synthesized Photolyase mRNA
2015 StandoutNobel
bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death
1993 Standout
C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2
1994 StandoutNobel
Genetic Alterations of Cyclins, Cyclin-Dependent Kinases, and Cdk Inhibitors in Human Cancer
1996
A Gain-of-Function Mutation of JAK2 in Myeloproliferative Disorders
2005 Standout
Activation of C. elegans cell death protein CED-9 by an ammo-acid substitution in a domain conserved in Bcl-2
1994 StandoutNatureNobel
Mammalian G1 cyclins
1993 Standout
Patterned Hydrogels for Controlled Platelet Adhesion from Whole Blood and Plasma
2010 StandoutNobel
Nonmyeloablative HLA-Matched Sibling Allogeneic Hematopoietic Stem Cell Transplantation for Severe Sickle Cell Phenotype
2014
Therapeutic targeting of Janus kinases
2008
AID-deficient Bcl-xL transgenic mice develop delayed atypical plasma cell tumors with unusual Ig/Myc chromosomal rearrangements
2007 StandoutNobel
Genomic organization of IgH gene compared with the expression of Bcl-2 gene in t(14;18)-positive lymphoma
1991 StandoutNobel
Activation Of Cellular Oncogenes in Hemopoietic Cells by Chromosome Translocation
1986
Clustering of breakpoints on chromosome 11 in human B-cell neoplasms with the t(11 ; 14) chromosome translocation
1985 Nature
Multiple chromosomally distinct cell populations in myelodysplastic syndromes and their possible significance in the evolution of the disease
1986
ONCOGENE ACTIVATION BY CHROMOSOME TRANSLOCATION IN HUMAN MALIGNANCY
1987
Clonal expansion of immunoglobulin M+CD27+ B cells in HCV-associated mixed cryoglobulinemia
2007 StandoutNobel
Preparation and characterization of affinity magnetoliposomes useful for the detection of antiphospholipid antibodies
2001
Apoptosis in the Pathogenesis and Treatment of Disease
1995 StandoutScience
Magnetic Iron Oxide Nanoparticles: Synthesis, Stabilization, Vectorization, Physicochemical Characterizations, and Biological Applications
2008 Standout
Cancer Cell Cycles
1996 StandoutScience
A FOS protein is present in a complex that binds a negative regulator of MYC.
1989 StandoutNobel
Occurrence, Biogenesis, and Synthesis of Biologically Active Carbazole Alkaloids
2012 Standout
Immunophenotyping of leukemias using a cluster of differentiation antibody microarray.
2001
Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma.
1986
PRAD1, a candidate BCL1 oncogene: mapping and expression in centrocytic lymphoma.
1991
Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death
1993 Standout
Identification of a human transcription unit affected by the variant chromosomal translocations 2;8 and 8;22 of Burkitt lymphoma.
1989 StandoutNobel
Retinoblastoma Protein Contains a C-terminal Motif That Targets It for Phosphorylation by Cyclin-cdk Complexes
1999 StandoutNobel
Regulatory elements that modulate expression of human c-myc.
1987 StandoutNobel
Detailed Molecular Delineation of 13q14.3 Loss in B-Cell Chronic Lymphocytic Leukemia
1998
p53 Represses Cyclin D1 Transcription through Down Regulation of Bcl-3 and Inducing Increased Association of the p52 NF-κB Subunit with Histone Deacetylase 1
2003
Regulation of retinoblastoma protein functions by ectopic expression of human cyclins
1992 Standout
Mutation Analysis of the Rearranged Immunoglobulin Heavy Chain Genes of Marginal Zone Cell Lymphomas Indicates an Origin From Different Marginal Zone B Lymphocyte Subsets
1998
The Molecular Genetics of Cancer
1987 StandoutScienceNobel
Fusion of TEL, the ETS-Variant Gene 6 (ETV6), to the Receptor-Associated Kinase JAK2 as a Result of t(9; 12) in a Lymphoid and t(9; 15; 12) in a Myeloid Leukemia
1997
Evidence for nonclonal hematopoietic progenitor cell populations in bone marrow of patients with myelodysplastic syndromes
1994 StandoutNobel
Phase II study of 9-hydroxy-2N-methylellipticinium acetate
1984
B-Cell Chronic Lymphocytic Leukemia: A Bird of a Different Feather
1999
The cyclin D1 gene is a target of the β-catenin/LEF-1 pathway
1999 Standout
The t(14;18) Chromosome Translocations Involved in B-Cell Neoplasms Result from Mistakes in VDJ Joining
1985 Science
Distinctive demography, biology, and outcome of acute myeloid leukemia and myelodysplastic syndrome in children with Down syndrome: Children's Cancer Group Studies 2861 and 2891.
1998
Socs-1 Inhibits TEL-JAK2-Mediated Transformation of Hematopoietic Cells through Inhibition of JAK2 Kinase Activity and Induction of Proteasome-Mediated Degradation
2001
A 14;18 and an 8;14 chromosome translocation in a cell line derived from an acute B-cell leukemia.
1984
11q Deletions Identify a New Subset of B-Cell Chronic Lymphocytic Leukemia Characterized by Extensive Nodal Involvement and Inferior Prognosis
1997
Phase I clinical study of 9-hydroxy-2N-methyl-ellipticinium acetate (NSC-264137) administered on a 5-day i.v. schedule
1982
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
2016 Standout
Isolation and Synthesis of Biologically Active Carbazole Alkaloids
2002 Standout
t(11;14)-positive mantle cell lymphomas exhibit complex karyotypes and share similarities with B-cell chronic lymphocytic leukemia
2000
Works of A. Criel being referenced
Thrombocytopenia as Presenting Symptom of Preleukaemia in 3 Patients
1982
Trisomy 3 in marginal zone B‐cell lymphoma: a study based on cytogenetic analysis and fluorescence in situ hybridization
1996
Genetic abnormalities in chronic lymphocytic leukemia and their clinical and prognostic implications
1997
Platelet activation and vascular damage in gestational hypertension
1992
Chromosome 11q rearrangements in B non Hodgkin's lymphoma
1992
Trisomy 12 is uncommon in typical chronic lymphocytic leukaemias
1994
BCL3 rearrangement and t(14;19)(q32;q13) in lymphoproliferative disorders
1996
Comparative Study of Antiphospholipid Antibody Detection in Eleven Belgian Laboratories
1997
Standardisation of multiplex fluorescent short tandem repeat analysis for chimerism testing
2001
“Small” B-cell Non-Hodgkin's Lymphomas with Splenomegaly at Presentation Are Either Mantle Cell Lymphoma or Marginal Zone Cell Lymphoma
1996
The Concept of Typical and Atypical Chronic Lymphocytic Leukaemia
1999
Cobalamin absorption and serum homocysteine and methylmalonic acid in elderly subjects with low serum cobalamin
1993
Fusion of ETV6 to MDS1/EVI1 as a result of t(3;12)(q26;p13) in myeloproliferative disorders.
1997
High incidence of chromosome abnormalities in IgG3 myeloma
1984
Cytogenetic profile of minimally differentiated (FAB M0) acute myeloid leukemia: correlation with clinicobiologic findings [see comments]
1995
Drug Dependent Red Cell Antibodies and Intravascular Haemolysis Occurring in Patients Treated with 9 Hydroxy‐Methyl‐Ellipticinium
1980
Hypercalcaemia in Hodgkin's disease.
1986
Hypercalcaemia In Hodgkjn’S Disease
1986
FISH identifies different types of duplications with 12q13-15 as the commonly involved segment in B-cell lymphoproliferative malignancies characterized by partial trisomy 12
1997
Cytogenetic analysis of B cell chronic lymphoid leukemias classified according to morphologic and immunophenotypic (FAB) criteria.
1995